| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Pracinostat (SB939); Pracinostat (SB939) | CFN60428 | 929016-96-6 | C20H30N4O2 = 358.48 | 5mg | QQ客服：3257982914 |
| Oprozomib (ONX 0912); Oprozomib (ONX 0912) | CFN60429 | 935888-69-0 | C25H32N4O7S = 532.61 | 5mg | QQ客服：3257982914 |
| 氟伐他汀钠; Fluvastatin Sodium | CFN60430 | 93957-55-2 | C24H25FNNaO4 = 433.45 | 5mg | QQ客服：2159513211 |
| 度鲁特韦; Dolutegravir (GSK1349572) | CFN60431 | 1051375-16-6 | C20H19F2N3O5 = 419.38 | 5mg | QQ客服：3257982914 |
| WYE-354; WYE-354 | CFN60432 | 1062169-56-5 | C24H29N7O5 = 495.53 | 5mg | QQ客服：215959384 |
| 唑来膦酸; Zoledronic Acid | CFN60433 | 118072-93-8 | C5H10N2O7P2 = 272.09 | 5mg | QQ客服：3257982914 |
| 巴瑞克替尼; Baricitinib (INCB028050) | CFN60434 | 1187594-09-7 | C16H17N7O2S = 371.42 | 5mg | QQ客服：1413575084 |
| LY2811376; LY2811376 | CFN60435 | 1194044-20-6 | C15H14F2N4S = 320.36 | 5mg | QQ客服：2056216494 |
| 羟基脲; Hydroxyurea | CFN60436 | 127-07-1 | CH4N2O2 = 76.05 | 5mg | QQ客服：215959384 |
| 巴马司他; Batimastat (BB-94) | CFN60437 | 130370-60-4 | C23H31N3O4S2 = 477.64 | 5mg | QQ客服：2056216494 |
| TMP269; TMP269 | CFN60438 | 1314890-29-3 | C25H21F3N4O3S = 514.52 | 5mg | QQ客服：215959384 |
| 盐酸维拉帕米; Verapamil HCl | CFN60439 | 152-11-4 | C27H38N2O4.HCl = 491.06 | 5mg | QQ客服：1457312923 |
| 3-硝基-4-碘苯甲酰胺; Iniparib | CFN60440 | 160003-66-7 | C7H5IN2O3 = 292.03 | 5mg | QQ客服：215959384 |
| N1,N5,N10-(Z)-tri-p-coumaroylspermidine; N1,N5,N10-(Z)-tri-p-coumaroylspermidine | CFN95253 | 131086-78-7 | C34H37N3O6 = 583.7 | 5mg | QQ客服：1413575084 |
| Safflospermidine B; Safflospermidine B | CFN95254 | 1111082-11-1 | C34H37N3O6 = 583.7 | 5mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)